Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Goodman

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Cell Biology|September 17, 2002
Coming to grips with integrin binding to ligandsM Amin Arnaout, Simon L Goodman, Jian-Ping Xiong
Cancers|August 24, 2017
Integrins as Therapeutic Targets: Successes and CancersSabine Raab-Westphal, John F Marshall, Simon L Goodman
Journal of Hepatology|January 30, 2007
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitroEleonora Patsenker, Yury Popov, Matthias Wiesner, et al.
Blood|April 26, 2003
New insights into the structural basis of integrin activationJian-Ping Xiong, Thilo Stehle, Simon L Goodman, et al.
Journal of Medicinal Chemistry|February 22, 2002
Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrinsSimon L Goodman, Günter Hölzemann, Gábor A G Sulyok, et al.
The Journal of Biological Chemistry|August 10, 2004
A novel adaptation of the integrin PSI domain revealed from its crystal structureJian-Ping Xiong, Thilo Stehle, Simon L Goodman, et al.
Angiogenesis|October 18, 2008
Circulating and imaging markers for angiogenesisArvind P Pathak, Warren E Hochfeld, Simon L Goodman, et al.
Virchows Archiv : an International Journal of Pathology|November 27, 2013
Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progressionChristine Böger, Holger Kalthoff, Simon L Goodman, et al.
Angewandte Chemie (International Ed. in English)|December 14, 2004
Improving implant materials by coating with nonpeptidic, highly specific integrin ligandsClaudia Dahmen, Jörg Auernheimer, Axel Meyer, et al.
Gastroenterology|June 10, 2008
Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progressionEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Cell Biology|September 17, 2002
Coming to grips with integrin binding to ligandsM Amin Arnaout, Simon L Goodman, Jian-Ping Xiong
Cancers|August 24, 2017
Integrins as Therapeutic Targets: Successes and CancersSabine Raab-Westphal, John F Marshall, Simon L Goodman
Journal of Hepatology|January 30, 2007
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitroEleonora Patsenker, Yury Popov, Matthias Wiesner, et al.
Blood|April 26, 2003
New insights into the structural basis of integrin activationJian-Ping Xiong, Thilo Stehle, Simon L Goodman, et al.
Journal of Medicinal Chemistry|February 22, 2002
Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrinsSimon L Goodman, Günter Hölzemann, Gábor A G Sulyok, et al.
The Journal of Biological Chemistry|August 10, 2004
A novel adaptation of the integrin PSI domain revealed from its crystal structureJian-Ping Xiong, Thilo Stehle, Simon L Goodman, et al.
Angiogenesis|October 18, 2008
Circulating and imaging markers for angiogenesisArvind P Pathak, Warren E Hochfeld, Simon L Goodman, et al.
Virchows Archiv : an International Journal of Pathology|November 27, 2013
Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progressionChristine Böger, Holger Kalthoff, Simon L Goodman, et al.
Angewandte Chemie (International Ed. in English)|December 14, 2004
Improving implant materials by coating with nonpeptidic, highly specific integrin ligandsClaudia Dahmen, Jörg Auernheimer, Axel Meyer, et al.
Gastroenterology|June 10, 2008
Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progressionEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Pageof 5